This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
$0.35
Share price
4.59%
Change (1 day)
-74.82%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): C$0.95 Million
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is C$0.92 Million. In 2023 the company made a revenue of C$0.02 Million a decrease over the revenue in the year 2022 that were of C$0.36 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | C$0.95 M | 4593.51% |
| 2023 | C$0.02 M | -94.46% |
| 2022 | C$0.36 M | |
| 2021 | N/A | -100% |
| 2020 | C$0.04 M | -98.81% |
| 2019 | C$3.72 M | -3.35% |
| 2018 | C$3.85 M | -32.74% |
| 2017 | C$5.73 M | -20.8% |
| 2016 | C$7.24 M | 2.56% |
| 2015 | C$7.06 M | -71.78% |
| 2014 | C$25.02 M | 1104.64% |
| 2013 | C$2.07 M | 29.74% |
| 2012 | C$1.6 M | -66.11% |
| 2011 | C$4.72 M | 35.15% |
| 2010 | C$3.49 M | -13.48% |
| 2009 | C$4.04 M | 169.83% |
| 2008 | C$1.49 M | 55.88% |
| 2007 | C$0.96 M | 42.82% |
| 2006 | C$0.67 M | 114.87% |
| 2005 | C$0.31 M | |
| 2004 | N/A | -100% |
| 2003 | C$0.95 M | -24.09% |
| 2002 | C$1.25 M | 195.12% |
| 2001 | C$0.42 M |